Michael Parini, EVP, CL&AO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 8,392 shares at $245.52 ($2.0M) on 2020-02-18, disclosed to the SEC on 2020-02-19.
Seasonal sale ($2.0M) by EVP, CL&AO — this insider has traded VRTX in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $241.50 | 2,496 | $603K | 29.6% |
| 2 | $241.75 | 360 | $87K | 4.3% |
| 3 | $242.64 | 1,098 | $266K | 13.1% |
| 4 | $242.64 | 1,098 | $266K | 13.1% |
| 5 | $243.59 | 560 | $136K | 6.7% |
| 6 | $243.59 | 560 |
| $136K |
| 6.7% |
| 7 | $244.64 | 416 | $102K | 5.0% |
| 8 | $244.64 | 416 | $102K | 5.0% |
| 9 | $245.52 | 694 | $170K | 8.4% |
| 10 | $245.52 | 694 | $170K | 8.4% |
| Total | $243.06 avg | 8,392 | $2.0M | 100% |
| Filing → |
| VRTX | SELL | 2021-02-16 | $1.7M | — | Filing → |
| VRTX | SELL | 2021-02-09 | $415K | — | Filing → |
| VRTX | SELL | 2021-02-05 | $87K | — | Filing → |